
1. intervirology. 2007;50(6):412-7. doi: 10.1159/000112916. epub 2008 jan 8.

chlorpromazine combined cidofovir treatment patient suffering 
progressive multifocal leukoencephalopathy.

pöhlmann c(1), hochauf k, röllig c, schetelig j, wunderlich o, bandt d, ehninger 
g, jacobs e, rohayem j.

author information: 
(1)institut für medizinische mikrobiologie und hygiene, dresden, deutschland.

we report stem cell-transplanted patient b cell chronic lymphatic
leukemia presented subacute onset focal neurological deficits, gait
abnormalities, emotional lability dementia. progressive multifocal
leukoencephalopathy diagnosed magnetic resonance imaging (mri) the
brain detection jc virus genome cerebrospinal fluid. cidofovir 
the 5ht2a receptor antagonist chlorpromazine subsequently administered. a
follow-up mri brain 2 weeks initiation antiviral therapy
displayed progress demyelination, patient died 3 months after
onset neurological symptoms. report highlights need the
development novel potent strategies treatment progressive
multifocal leukoencephalopathy.

(c) 2008 s. karger ag, basel

doi: 10.1159/000112916 
pmid: 18182774  [indexed medline]

